Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_1054_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
23 Мб
Скачать
20
https://t.me/medicina_free
S. V. S. Deo et al.
Fig. 3.1 Planning of incisions for breast conservation surgery for tumors in different locations of the breast
Fig. 3.2 Part of skin close or adherent to tumor is included in the incision
a Circumareolar/Langer’s lines b Resting Skin Tension lines c Radial (inferior quadrant)
Infra-mammary
3 Principles ofPlanning Incisions forBreast Oncoplasty andReconstruction
https://t.me/medicina_free
21
mmary, peri-areolar, and axillary location (Fig.3.5) [4]. The incision may be placed directly overlying the tumor or away from tumor with tunneling for tumor access (indirect approach). Axillary surgery can be done using the same incision for upper outer quadrant and axillary tail tumors; otherwise, a separate incision placed behind anterior axillary fold should be used for axillary surgery.
Preoperatively anthropometric assessment of the patient and breast should be done. The shape of breast, degree of ptosis, NAC size and posi­tion, and tumor location should be documented in sitting as well as standing position. The measure­ments and incision on the skin should be marked
preoperatively and modications should be made, if required, by assessing them in sitting and standing position. Preoperative photographs in sitting and standing position should be taken for documentation, after due consent. This will help in planning the reconstruction options and also will be helpful in dealing with medicolegal issues in future, if any.
Intraoperatively, the patient should be ade­quately exposed (i.e. including the contralateral breast) and should be positioned in semi- reclining position and have a symmetrical arm positioning. The markings and measurements should be rechecked intraoperatively (Fig.3.6).
Trans-axillary
Fig. 3.3 Previous surgical scar included in the denitive surgical planning
Fig. 3.4 Planning of incisions in relation to Langer’s lines
Peri-areolar
Fig. 3.5 Anatomical locations where surgical scars can be hidden
22
https://t.me/medicina_free
Fig. 3.6 Positioning of the patient, measurements and markings of breast for complex breast surgeries
3.2 Incision Planning forMastectomy
Non-skin sparing mastectomy (NSSM), skin sparing mastectomy (SSM), skin reducing mas­tectomy (SRM), nipple–areola sparing mastec­tomy (NASM) are the four types of mastectomies
S. V. S. Deo et al.
commonly performed. Elliptical incision includ­ing NAC (except for NASM) and surrounding skin can be utilized by placing transversely or with an upward angle toward axilla. Transverse incision is preferred in large breasted women, while a sigmoid or modied wise pattern incision is recommended for the small breasted women. Incisions should not cross normal anatomical boundaries of the breast such as clavicle, inframammary crease, sternal border, and the axillary fold.
Flaps should not be raised beyond inframam­mary crease, unless required. The infra- mammary crease should be marked preoperatively. Uninvolved skin should be preserved if delayed or secondary reconstruction is planned.
Inframammary crease or lateral mammary incisions may be used in cases of skin sparing or NAC sparing mastectomy in patients with small sized breast (Fig. 3.7) [5]. Other incisions that may be used for NASM or SSM are peri-areolar, trans-areolar, trans-areolar and trans-nipple, lat­eral mammary crease, italic “S” (Fig.3.8) [6].
3 Principles ofPlanning Incisions forBreast Oncoplasty andReconstruction
https://t.me/medicina_free
Fig. 3.7 Nipple sparing mastectomy using an inframammary incision with implant reconstruction in a case of multi­centric breast cancer
Fig. 3.8 Various incisions and approaches for skin sparing and nipple–areola sparing mastectomy
23
3.3 Conclusion
Judicious planning of incisions is extremely important to achieve good cosmetic outcomes in breast oncoplasty. It requires familiarity with anatomy, oncologic principles, and plastic surgi­cal techniques. The incision planning should be individualized and should be tailored to patient, tumor, and treatment needs. It should aim at bal­ancing oncologic and cosmetic outcomes.
References
1. Moufarrège R, Dionyssopoulos A, Aymeric A,
Sauvageau J. Is there a relation between mamma-
plasties incisions and the nal shape of the breast?
Ann Chir Plast Esthet. 2010;55:111–34. https://doi.
org/10.1016/j.anplas.2009.04.006.
2. Mitchell SD. A step-by-step oncoplastic breast con-
servation surgical atlas of reproducible dissection
techniques and anatomically ideal incision placement.
Breast Cancer Res Treat. 2017;165:505–16. https://
doi.org/10.1007/s10549- 017- 4344- z.
24
https://t.me/medicina_free
S. V. S. Deo et al.
3. Skaria AM. Incision lines on the female breast. DRM. 2020;236:248–50. https://doi.
org/10.1159/000505541.
4. Seki H, Sakurai T, Maeda Y, et al. Utility of the periareolar incision technique for breast reconstruc­tive surgery in patients with breast cancer. Surg Today. 2020;50:1008–15. https://doi.org/10.1007/
s00595- 020- 01975- y.
5. Daar DA, Abdou SA, Rosario L, et al. Is there a preferred incision location for nipple-sparing mas-
tectomy? A systematic review and meta-analysis. Plast Reconstr Surg. 2019;143:906e–19e. https://doi.
org/10.1097/PRS.0000000000005502.
6. Rawlani V, Fiuk J, Johnson SA, et al. The effect of incision choice on outcomes of nipple-sparing mastec­tomy reconstruction. Can J Plast Surg. 2011;19:129–
33. https://doi.org/10.1177/229255031101900410.
Oncologic Principles ofBreast
https://t.me/medicina_free
Conservation andOncoplastic Breast Surgery
DillipKumarMuduly andMadhabanandaKar
4
4.1 Introduction
Breast conservation surgery (BCS) refers to resection of the tumor with a three-dimensional grossly free margin, along with the preservation of cosmesis. The term breast conservation ther­apy (BCT) is interchangeably used with BCS; however, BCT means incorporating locoregional radiotherapy and BCS.BCS require good surgi­cal skills and experience and quality BCS is of paramount importance for any successful onco­plastic breast surgical procedure.
4.2 Clinical Evaluation andStaging
The patients with early breast cancer present with a breast lump or may be detected on a screening method. Triple assessment is mandatory in all patients, including clinical examination, imaging of breast (ultrasound and/or mammogram), and a tissue diagnosis (core-cut biopsy). A guided core­cut biopsy always gives better results. In addition to histopathology; immunohistochemistry for Estrogen Receptor (ER), Progesterone Receptor (PR), and Her2neu are done in all patients, par­ticularly those planned for neoadjuvant chemo-
D. K. Muduly (*) · M. Kar Department of Surgical Oncology, All India Institute of Medical Sciences, Bhubaneswar, India
therapy. Staging is performed clinically using AJCC/TNM staging method. For clinical stage I and II, no further metastatic staging investiga­tions are required. For clinical stage III and IV, we need to perform CECT Chest, abdomen, and pelvis with Bone scan/PET scan alone as staging investigation [1].
4.3 Local Imaging
All patients undergo a bilateral mammogram at the time of presentation. Digital mammography is preferred to analog mammography, particu­larly for women with dense breasts. The mam­mogram will tell if there is any lesion, whether the lesion is solitary/multiple, the size and loca­tion of the lesion, whether unilateral or bilateral, and the ACR density category. Information on the mammogram helps in deciding whether BCS is feasible or not. The ACR density category is one of the factors in deciding the type of oncoplastic surgery to be planned.
Ultrasound of the breast is usually performed to conrm the results of a mammogram. The USG of the breast would help inlocalizing and characterizing any lesion, site, size, and the num­ber of lesions, distance from the skin, pectoral fascia, and nipple-areolar margin. Ultrasound is also used to guide a biopsy and may be used intra-operatively to localize and guide an ade­quate resection margin. The USG of the axilla is
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023 S. V. S. Deo (ed.), Breast Oncoplasty and Reconstruction,
https://doi.org/10.1007/978-981-99-5536-7_4
25
26
https://t.me/medicina_free
D. K. Muduly and M. Kar
performed in all patients with early breast cancer to see for any suspicious nodes before planning for a sentinel node biopsy.
Although highly sensitive, magnetic resonance imaging (MRI) of the breast is not performed rou­tinely due to its low specicity. However, MRI may be performed in addition to mammogram and ultrasound in; (a) unknown primary with an axillary nodal metastasis where clinical examina­tion and conventional imaging has failed to detect the primary lesion [2, 3], (b) There remains a high suspicion for malignancy and US and needle biopsy have not made a diagnosis [4], (c) The patient has lobular cancer, and wide local excision is being considered, (d) The examination or initial imaging suggests there may be multi-focal dis­ease, (e) there is discordance regarding tumor size between the clinical examination and initial imag­ing or the size of the tumor cannot be reliably assessed clinically or on imaging (this typically includes inltrating tumors, most notably lobular carcinomas, and when the tumor is occult on ini­tial imaging modalities). (f) The patient has sili­cone implants. (g) MRI guided biopsy of a lesion not visible on mammography or ultrasound.
4.4 Patient Selection forBreast
Conservation Surgery
All patients with early breast cancers without absolute contra-indications can be offered breast conservation as choice of treatment. Patients with EBC who are unt for upfront BCS due to large tumor size or adverse tumor versus breast ratio can be offered NACT to downstage the disease and facilitate BCS.
4.4.1 Absolute Contra-indications
forBCT
4.4.1.1 Contra-indication at
Presentation
If the patient is in the rst trimester of pregnancy at presentation, she should be treated with mas-
tectomy. If she presents in the second or third tri­mester, she can be managed with BCS followed by adjuvant chemotherapy or NACT followed by surgery. Adjuvant RT can be administered postpartum.
4.4.1.2 Contra-indication Based onPast-history
History of prior irradiation to the chest wall.
4.4.1.3 Contra-indication onClinical Examination
If on examination, multicentric disease is there with two or more lumps, and they cannot be resected without compromising cosmesis.
4.4.1.4 Contra-indication onInvestigation
Diffuse appearing malignant microcalcication on the mammogram.
4.4.1.5 Contra-indication Detected On-table During Surgery (Frozen)/Post-Surgery (Paran Sections)
Persistent margin positive (cavity shave) after re­resection of a positive margin.
4.4.2 Relative Contra-indications toBCT
4.4.2.1 Connective Tissue Diseases
Some of the patients with connective tissue disorders tolerate poorly to radiotherapy. Patients with Scleroderma, Sjogren’s Syndrome have higher complications due to skin fragility. Systemic Lupus erythematosus and rheumatoid arthritis patients also have an increased risk of skin toxicity. In recent stud­ies, there was no significant difference in the incidence of acute or late complications. However, there was a higher incidence of radi­ation complications in patients with sclero­derma. No fatal complication were noted in any of the patients [5].
4 Oncologic Principles ofBreast Conservation andOncoplastic Breast Surgery
https://t.me/medicina_free
27
4.4.2.2 Tumor Breast Ratio
This is dened as tumor size relative to breast size and is an essential factor in selecting patients for BCT.A large tumor in a small breast is a rela­tive contra-indication since an adequate resection would signicantly alter cosmetic alteration. However, now-a-days, these patients may undergo BCT with oncoplastic techniques/NACT followed by BCT with/without oncoplasty.
4.4.2.3 Pendulous Breast
A pendulous breast was previously a contra­indication for BCT due to difculty in reproduc­ibility of radiation dose homogeneity. However, these patients are no longer a contra-indication if the dose homogeneity can be ensured.
4.4.3 Factors No Longer Contra­indication toBCT
4.4.3.1 Age
Older age is no longer a contra-indication for sur­gery. In contrary, they have a lower risk of recur­rence, and they should be offered with BCT if there is no other contra-indication.
4.4.3.2 Tumor Location
Although the patients with a medial tumor are challenging to reconstruct, they are not contra­indications for BCT. With oncoplastic surgery, these patients are increasingly taken up for breast conservation.
4.4.3.3 Invasive Lobular Carcinoma
If resected up to negative margins, it’s not a contra- indication. The presence of classic LCIS at the resection margin does not increase the recurrence rates and does not bear a clinical sig­nicance and does not need a re-resection of the margin.
4.4.3.4 Extensive Intraductal Component (EIC)
Extensive intraductal component (EIC) means presence of >25% volume of DCIS component present in the resected lumpectomy specimen, in a patient with invasive tumor. The EIC does not
apply to a tumor that is pure DCIS. The EIC­positive cancers with negative resection margins do not have an increased risk of ipsilateral recur­rence following BCT [6].
4.4.3.5 Family History ofBreast Cancer
Patients with family history of breast cancer are not contra-indication for BCT. However, they should be informed that, they have a higher risk of increased second primary cancers [7].
4.4.3.6 Lymph Node Positivity
Presence of positive lymph node is a marker for poor prognosis with increased distant recurrence and not a contra-indication for BCT.Node posi­tive patients undergoing mastectomy or BCT have similar outcomes.
4.4.4 Principles ofNeoadjuvant Chemotherapy Followed byBCT
Patients with early breast cancer unsuitable for BCT due to large tumor size may be planned for NACT followed by BCS. The NACT increases the BCT rate; however, it does not impact recur­rence or survival. However, all patients receiving NACT should have undergone a core-cut biopsy with the evaluation of ER, PR, and Her2neu sta­tus before chemotherapy. Those with negative hormone receptors and Her2neu negative tumors show the highest response rate. Those with hor­mone receptor-positive and HER2 negative are less likely to respond to NACT or become eligi­ble for BCT.Meticulous clinical and radiological evaluation by the treating surgeon, precise docu­mentation of clinical ndings, metal marker placement in the tumor prior to NACT are essen­tial prerequisites for NACT - BCS protocols. Post-chemotherapy assessment includes clinical and radiological evaluation. Wire-guided local­ization or any other localization method should be used to target tumor bed with metal marker. Volume of excision should be as per post-NACT residual tumor burden. Specimen mammography should be performed to conrm excision of target lesion.
28
https://t.me/medicina_free
4.5 Surgical Principles
The incision should be planned according to the tumor location and breast anatomy. No excessive tunneling should be performed. During resection care is taken to take adequate grossly normal margin (usually 1cm) around the tumor. There are different techniques to ensure a gross margin of 1 cm around the tumor. The most common technique used by the surgeons is Palpation Guided Resection for palpable lesions. The sur­geon palpates the lesion after raising the aps when required, and the nger placed on the tumor margin helps ensure a 1cm gross normal tissue margin (Fig. 4.1). The USG can be used (Ultrasound-Guided Resection), particularly in non-palpable or indistinct lesions, to localize and accurately ensure margins (Fig.4.2). Other tech­niques used for non-palpable lesions are wire-
D. K. Muduly and M. Kar
Fig. 4.2 Ultrasound-Guided Resection
Fig. 4.1 Finger Guided Resection with gross normal margin. (Art: Dr. Dipin)
4 Oncologic Principles ofBreast Conservation andOncoplastic Breast Surgery
https://t.me/medicina_free
guided resection, radio-guided occult lesion localization (ROLL), radioactive iodine (I-125) seed localization (RSL), and cryo-assisted local­ization (CAL) techniques.
4.5.1 Breast Conservation Surgery– Margin Status
There are two types of margins described. One is the lumpectomy margin, which can be assessed by the following methods. After resection, the sur­geon can assess the lumpectomy margin by pal- pating the resected lumpectomy specimen for any gross margin positivity. The surgeon takes sec- tions on the resected primary specimen along dif­ferent margins (Fig. 4.3). Ultrasound of the lumpectomy specimen may be performed to ensure the adequacy of gross margin (Fig.4.4). The specimen may be sent for specimen mam- mogram to see for adequacy of margins, particu­larly in non-palpable lesions (Fig.4.5). The other is, taking margin specimen separately from the resected cavity, also called cavity shave margins (Fig.4.6). If available, many centers perform fro­zen section biopsy or imprint cytology of the lumpectomy or cavity shave margins, which gives an accurate intra-operative microscopic margin status and reduces the positive margin rate and
Fig. 4.4 Intra-operative margin assessment by ultra­sound. (Post-resection)
rate of re-resection. Two randomized trials have shown cavity shave margin reduces the margin positive rate by 50%. We at our institute routinely perform cavity shave margins intra- operatively and perform frozen section biopsy. Any positive margin is immediately subjected to further re­resection/mastectomy based on circumstances [8,
9].
Different newer, lesser invasive, and faster technologies have been described that accurately predict the microscopic margin status; however, they are costly and unavailable at many centers, e.g., MarginProbe, which uses spectroscopy, and Lumicell, which uses uorescent imaging as the principle.
Microscopic margin status is the most crucial factor in BCT, and the currently microscopic pos­itive margin is dened as “ink-on-tumor”. A neg­ative microscopic margin is dened as “no ink on tumor” [10] (Table4.1).
29
Fig. 4.3 Cut-section of the specimen to assess the gross margin
4.5.2 Metal Marker Placement
ontheResection Cavity
After resection, meticulous hemostasis must be obtained. Metallic titanium clips are placed on the margins before closure to help the radiation oncologist identify the cavity for tumor boost. Routinely a clip is placed in each medial, lateral, superior, inferior, and deep margins of the resec­tion cavity (Fig.4.7).